Aspiriant LLC’s Goldman Sachs GS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.23M | Buy |
1,214
+228
| +23% | +$222K | 0.03% | 157 |
|
|
2026
Q1 | $834K | Sell |
986
-12
| -1% | -$10.7K | 0.02% | 169 |
|
|
2025
Q4 | $877K | Buy |
998
+122
| +14% | +$99.5K | 0.03% | 169 |
|
|
2025
Q3 | $698K | Sell |
876
-127
| -13% | -$94.1K | 0.02% | 178 |
|
|
2025
Q2 | $710K | Sell |
1,003
-22
| -2% | -$12.7K | 0.02% | 172 |
|
|
2025
Q1 | $560K | Buy |
1,025
+44
| +4% | +$26.5K | 0.02% | 179 |
|
|
2024
Q4 | $562K | Buy |
981
+54
| +6% | +$30.1K | 0.02% | 181 |
|
|
2024
Q3 | $459K | Sell |
927
-447
| -33% | -$219K | 0.02% | 193 |
|
|
2024
Q2 | $621K | Sell |
1,374
-413
| -23% | -$181K | 0.03% | 175 |
|
|
2024
Q1 | $746K | Sell |
1,787
-41
| -2% | -$15.9K | 0.03% | 163 |
|
|
2023
Q4 | $705K | Buy |
1,828
+395
| +28% | +$132K | 0.03% | 167 |
|
|
2023
Q3 | $464K | Buy |
1,433
+179
| +14% | +$59.8K | 0.02% | 186 |
|
|
2023
Q2 | $404K | Buy |
1,254
+239
| +24% | +$78.6K | 0.02% | 193 |
|
|
2023
Q1 | $332K | Buy |
1,015
+29
| +3% | +$10.1K | 0.02% | 208 |
|
|
2022
Q4 | $339K | Buy |
986
+94
| +11% | +$32.7K | 0.02% | 204 |
|
|
2022
Q3 | $262K | Buy |
892
+155
| +21% | +$50.2K | 0.01% | 220 |
|
|
2022
Q2 | $218K | Sell |
737
-40
| -5% | -$12.5K | 0.01% | 252 |
|
|
2022
Q1 | $257K | Buy |
777
+1
| +0.1% | +$353 | 0.01% | 239 |
|
|
2021
Q4 | $298K | Buy |
776
+71
| +10% | +$28.1K | 0.02% | 230 |
|
|
2021
Q3 | $266K | Sell |
705
-16
| -2% | -$6.25K | 0.02% | 204 |
|
|
2021
Q2 | $274K | Buy |
721
+12
| +2% | +$4.29K | 0.02% | 205 |
|
|
2021
Q1 | $232K | Buy |
+709
| New | +$221K | 0.01% | 193 |
|
|
2019
Q3 | – | Sell |
-980
| Closed | -$200K | – | 222 |
|
|
2019
Q2 | $200K | Buy |
+980
| New | +$194K | 0.02% | 224 |
|
|
2019
Q1 | – | Sell |
-1,697
| Closed | -$285K | – | 237 |
|
|
2018
Q4 | $285K | Buy |
+1,697
| New | +$342K | 0.02% | 190 |
|
|
2018
Q3 | – | Sell |
-1,807
| Closed | -$399K | – | 248 |
|
|
2018
Q2 | $399K | Buy |
1,807
+604
| +50% | +$144K | 0.03% | 180 |
|
|
2018
Q1 | $303K | Buy |
+1,203
| New | +$313K | 0.03% | 192 |
|
|
2017
Q2 | – | Sell |
-870
| Closed | -$200K | – | 217 |
|
|
2017
Q1 | $200K | Buy |
+870
| New | +$210K | 0.02% | 203 |
|
Other funds holding GS
Aspiriant LLC's GS Position: Q2 2026 in Review
Aspiriant LLC increased its Goldman Sachs (GS) stake by 23% in Q2 2026, buying an estimated $222K and bringing the position to 1,214 shares worth $1.23M. The position accounts for 0.03% of the portfolio, ranked #157.
Aspiriant LLC first reported a position in GS in Q1 2017 and has held it in 27 quarters since. 3,157 funds tracked by Wall St. Rank hold GS as of Q2 2026.
- Aspiriant LLC held 1,214 shares of Goldman Sachs worth $1.23M as of Q2 2026.
- Aspiriant LLC bought 228 Goldman Sachs shares in Q2 2026, an estimated $222K.
- Goldman Sachs made up 0.03% of Aspiriant LLC's portfolio in Q2 2026, its #157 holding.
- Aspiriant LLC first reported a position in Goldman Sachs in Q1 2017 and has held it in 27 quarters since.
- 3,157 funds tracked by Wall St. Rank held Goldman Sachs as of Q2 2026.
Based on Aspiriant LLC's 13F filing for Q2 2026, filed 20 Jul 2026.